Literature DB >> 25654651

The sheddase ADAM10 is a potent modulator of prion disease.

Hermann C Altmeppen1, Johannes Prox2, Susanne Krasemann1, Berta Puig1, Katharina Kruszewski3, Frank Dohler1, Christian Bernreuther1, Ana Hoxha1, Luise Linsenmeier1, Beata Sikorska4, Pawel P Liberski4, Udo Bartsch3, Paul Saftig2, Markus Glatzel1.   

Abstract

The prion protein (PrP(C)) is highly expressed in the nervous system and critically involved in prion diseases where it misfolds into pathogenic PrP(Sc). Moreover, it has been suggested as a receptor mediating neurotoxicity in common neurodegenerative proteinopathies such as Alzheimer's disease. PrP(C) is shed at the plasma membrane by the metalloprotease ADAM10, yet the impact of this on prion disease remains enigmatic. Employing conditional knockout mice, we show that depletion of ADAM10 in forebrain neurons leads to posttranslational increase of PrP(C) levels. Upon prion infection of these mice, clinical, biochemical, and morphological data reveal that lack of ADAM10 significantly reduces incubation times and increases PrP(Sc) formation. In contrast, spatiotemporal analysis indicates that absence of shedding impairs spread of prion pathology. Our data support a dual role for ADAM10-mediated shedding and highlight the role of proteolytic processing in prion disease.

Entities:  

Keywords:  ADAM10; infectious disease; microbiology; mouse; neurodegeneration; neuroscience; prion disease; proteolytic processing; shedding

Mesh:

Substances:

Year:  2015        PMID: 25654651      PMCID: PMC4346534          DOI: 10.7554/eLife.04260

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  107 in total

1.  Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie.

Authors:  N A Mabbott; F Mackay; F Minns; M E Bruce
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Spontaneous generation of anchorless prions in transgenic mice.

Authors:  Jan Stöhr; Joel C Watts; Giuseppe Legname; Abby Oehler; Azucena Lemus; Hoang-Oanh B Nguyen; Joshua Sussman; Holger Wille; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 3.  Immune system and peripheral nerves in propagation of prions to CNS.

Authors:  Adriano Aguzzi; Frank L Heppner; Mathias Heikenwalder; Marco Prinz; Kirsten Mertz; Harald Seeger; Markus Glatzel
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

4.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

5.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation.

Authors:  E Casanova; S Fehsenfeld; T Mantamadiotis; T Lemberger; E Greiner; A F Stewart; G Schütz
Journal:  Genesis       Date:  2001-09       Impact factor: 2.487

6.  The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.

Authors:  Ulrike K Resenberger; Anja Harmeier; Andreas C Woerner; Jessica L Goodman; Veronika Müller; Rajaraman Krishnan; R Martin Vabulas; Hans A Kretzschmar; Susan Lindquist; F Ulrich Hartl; Gerd Multhaup; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  EMBO J       Date:  2011-03-25       Impact factor: 11.598

7.  The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).

Authors:  Jessie A Turnbaugh; Ursula Unterberger; Paula Saá; Tania Massignan; Brian R Fluharty; Frederick P Bowman; Michael B Miller; Surachai Supattapone; Emiliano Biasini; David A Harris
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

8.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

9.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.

Authors:  Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

10.  A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.

Authors:  Alex J McDonald; Jessie P Dibble; Eric G B Evans; Glenn L Millhauser
Journal:  J Biol Chem       Date:  2013-11-18       Impact factor: 5.157

View more
  30 in total

1.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

Review 2.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

3.  Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.

Authors:  Brent Race; Martin Jeffrey; Gillian McGovern; David Dorward; Bruce Chesebro
Journal:  Prion       Date:  2017-07-31       Impact factor: 3.931

4.  Prion 2016 Poster Abstracts.

Authors: 
Journal:  Prion       Date:  2016       Impact factor: 3.931

5.  The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.

Authors:  Tobias Brummer; Martina Pigoni; Armando Rossello; Huanhuan Wang; Peter J Noy; Michael G Tomlinson; Carl P Blobel; Stefan F Lichtenthaler
Journal:  FASEB J       Date:  2018-02-07       Impact factor: 5.191

6.  In vivo regulation of the A disintegrin and metalloproteinase 10 (ADAM10) by the tetraspanin 15.

Authors:  Lisa Seipold; Hermann Altmeppen; Tomas Koudelka; Andreas Tholey; Petr Kasparek; Radislav Sedlacek; Michaela Schweizer; Julia Bär; Marina Mikhaylova; Markus Glatzel; Paul Saftig
Journal:  Cell Mol Life Sci       Date:  2018-03-08       Impact factor: 9.261

7.  The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6.

Authors:  Alexander Küffer; Asvin K K Lakkaraju; Amit Mogha; Sarah C Petersen; Kristina Airich; Cédric Doucerain; Rajlakshmi Marpakwar; Pamela Bakirci; Assunta Senatore; Arnaud Monnard; Carmen Schiavi; Mario Nuvolone; Bianka Grosshans; Simone Hornemann; Frederic Bassilana; Kelly R Monk; Adriano Aguzzi
Journal:  Nature       Date:  2016-08-08       Impact factor: 49.962

Review 8.  The role of prion strain diversity in the development of successful therapeutic treatments.

Authors:  Sara A M Holec; Alyssa J Block; Jason C Bartz
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-28       Impact factor: 3.622

9.  A soluble derivative of PrPC activates cell-signaling and regulates cell physiology through LRP1 and the NMDA receptor.

Authors:  Elisabetta Mantuano; Pardis Azmoon; Michael A Banki; Michael S Lam; Christina J Sigurdson; Steven L Gonias
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

10.  Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions.

Authors:  Patricia Aguilar-Calvo; Alejandro M Sevillano; Jaidev Bapat; Katrin Soldau; Daniel R Sandoval; Hermann C Altmeppen; Luise Linsenmeier; Donald P Pizzo; Michael D Geschwind; Henry Sanchez; Brian S Appleby; Mark L Cohen; Jiri G Safar; Steven D Edland; Markus Glatzel; K Peter R Nilsson; Jeffrey D Esko; Christina J Sigurdson
Journal:  Acta Neuropathol       Date:  2019-10-31       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.